SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (80)6/8/2001 3:08:17 PM
From: tuck  Read Replies (1) of 1005
 
BLUE HP manager back in one piece -- but many pieces with nicks -- from vacation in climbing mecca, Yosemite. Still able to type, so nibbling 500 shares of KOSN at $9.20. Next target, $7.50.

Thanks for y'all's help on INGN's licensing situation. Anybody know who's in the lead -- in terms of filing for marketing approval -- in the area of gene therapy using adenoviral vectors? In other words, what company is the regulatory bellwether for INGN, if the FDA's standards are expected to be stringent?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News